Samsung Pharmaceutical
KOSPI · Healthcare · ₩130B
₩1,374-0.22%
Price
1430.0원
1374.0원
Jun 15, 26Sep 11, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
6/'26
Revenue₩9.9B+9.8%
Operating Income-₩5.0B-163.4%
Net Income-₩56.6BTurned to loss
3/'26 vs prev quarter
Company Health
Market Cap₩130B
Operating Margin-37.8%
Cash on Hand96억원7.4% of market cap
Free Cash Flow-58억원-4.5% of market cap
Short Volume 5.6% · as of 26.09.11
Among 98 제약 peers
LowMedianHigh
PSR3.0xmedian 0.8xPBR1.8xmedian 0.8xROE-189.8%median +4.9%
